Michal J. Walczak, PhD .

 Michal J. Walczak, PhD

 

Michal J. Walczak as a CSO oversees all the scientific activities at Captor from target selection, building protein degradation platform, importing expertise and technology implementation.

Prior to Captor, Michal trained at Friedrich Miescher Institute (Novartis Research Foundation) in Basel, where he studied modulation of E3 ubiquitin ligases.

Michal received his PhD from ETH Zurich working at the interface of biophysics, biochemistry and drug discovery.

Michal co-founded also an Alphamoon company, dedicated to artificial intelligence and its applications in life science.

Show map